Exports of U.S.-Origin Highly Enriched Uranium (HEU) for Medical Isotope Production: Certification of Sufficient Supplies of Non-HEU-based Molybdenum-99 (Mo-99) To Meet Needs of Patients in the United States, 73270-73271 [2021-28017]
Download as PDF
<![CDATA[
73270
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
On December 1, 2021, the
Office of Nuclear Energy, Department of
Energy, published a request for
information in the Federal Register on
how to site federal facilities for the
temporary, consolidated storage of spent
nuclear fuel using a consent-based
approach. This document corrects
broken hyperlinks to the Invitation for
Public Comment and to the 2017 Draft
Consent-Based Siting Process for
Consolidated Storage and Disposal
Facilities for Spent Nuclear Fuel and
High-Level Radioactive Waste.
FOR FURTHER INFORMATION CONTACT:
Please send any questions to
consentbasedsiting@hq.doe.gov, or to
Alisa Trunzo at 301–903–9600.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Correction
In the Federal Register of December 1,
2021, FR Doc. 2021–25724, (86 FR
68244) under the SUPPLEMENTARY
INFORMATION section, the following
corrections are made:
(1) First column, first paragraph, lines
9 thru 11, the weblink is corrected as
follows:
https://www.energy.gov/sites/prod/
files/2016/12/f34/Summary%20of
%20Public%20Input%20Report
%20FINAL.pdf.
(2) First column, first paragraph, lines
22 thru 25, the weblink is corrected as
follows:
https://www.energy.gov/sites/prod/
files/2017/01/f34/Draft%20ConsentBased%20Siting%20Process%20and
%20Siting%20Considerations.pdf.
(3) First column, fourth paragraph,
under the heading, Questions for Input,
lines 9 thru 11, the weblink is corrected
as follows:
https://www.energy.gov/sites/prod/
files/2017/01/f34/Draft%20ConsentBased%20Siting%20Process%20and
%20Siting%20Considerations.pdf.
(4) Second column, under the
heading, Area 1: Consent-Based Siting
Process, paragraph 7, the weblink is
corrected as follows:
https://www.energy.gov/sites/prod/
files/2017/01/f34/Draft%20ConsentBased%20Siting%20Process%20and
%20Siting%20Considerations.pdf.
Reason for Correction: The change
aims to fix the standard hyperlink
format accepted by the FRN template.
Signing Authority
This document of the Department of
Energy was signed on December 15,
2021, by Dr. Kathryn Huff, Principal
Deputy Assistant Secretary for the
Office of Nuclear Energy, pursuant to
delegated authority from the Secretary
of Energy. That document with the
original signature and date is
maintained by DOE. For administrative
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
purposes only, and in compliance with
requirements of the Office of the Federal
Register, the undersigned DOE Federal
Register Liaison Officer has been
authorized to sign and submit the
document in electronic format for
publication, as an official document of
the Department of Energy. This
administrative process in no way alters
the legal effect of this document upon
publication in the Federal Register.
Signed in Washington, DC, on December
21, 2021.
Treena V. Garrett,
Federal Register Liaison Officer, U.S.
Department of Energy.
[FR Doc. 2021–28009 Filed 12–23–21; 8:45 am]
BILLING CODE 6450–01–P
DEPARTMENT OF ENERGY
National Nuclear Security
Administration
Exports of U.S.-Origin Highly Enriched
Uranium (HEU) for Medical Isotope
Production: Certification of Sufficient
Supplies of Non-HEU-based
Molybdenum-99 (Mo-99) To Meet
Needs of Patients in the United States
National Nuclear Security
Administration (NNSA), Department of
Energy (DOE).
ACTION: Notice.
AGENCY:
DOE and Department of
Health and Human Services (HHS), in
accordance with the American Medical
Isotopes Production Act of 2012
(AMIPA), have issued a joint Secretarial
certification that there is a sufficient
global supply of Mo-99 produced
without the use of HEU available to
meet the needs of patients in the United
States and that it is not necessary to
export United States-origin HEU for the
purposes of medical isotope production
in order to meet United States patient
needs. This certification is effective as
of January 2, 2022.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information may
be sent to Max Postman in the Office of
Conversion OfficeofConversion@
nnsa.doe.gov or 202–586–9114.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Authority and Background:
The American Medical Isotopes
Production Act of 2012 (AMIPA)
(subtitle F, Title XXXI of the National
Defense Authorization Act for Fiscal
Year 2013 (Pub. L. 112–139)), enacted
on January 2, 2013, amended section
134 of the Atomic Energy Act of 1954
(42 U.S.C. 2160d) by striking subsection
c. and inserting language that prohibits
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
the Nuclear Regulatory Commission
(NRC) from issuing a license for the
export of HEU from the United States
for the purposes of medical isotope
production, effective seven years after
enactment of AMIPA, subject to a
certification regarding the sufficiency of
Mo-99 supply in the United States.
AMIPA requires the Secretary of
Energy to either jointly certify, with the
Secretary of Health and Human
Services, that there is a sufficient supply
of Mo-99 produced without the use of
HEU available to meet U.S. patient
needs, and that it is not necessary to
export U.S.-origin HEU for the purposes
of medical isotope production in order
to meet U.S. patient needs, or to
unilaterally certify that there is
insufficient supply of Mo-99 produced
without the use of HEU available to
satisfy the domestic market and that the
export of U.S.-origin HEU for the
purposes of medical isotope production
is the most effective temporary means to
increase the supply of Mo-99 to the
domestic U.S. market, thereby delaying
the enactment of the export license ban
for up to six years.
DOE published a Federal Register
notice (85 FR 3362) on January 21, 2020
certifying that, at the time, there was an
insufficient global supply of Mo-99
produced without the use of HEU and
that the export of U.S.-origin HEU for
the purposes of medical isotope
production was the most effective
temporary means to increase the supply
of Mo-99 to the domestic U.S. market.
This certification was effective for no
more than two years from the effective
date of January 2, 2020. The Federal
Register notice stated that DOE would
conduct periodic reviews of the
domestic U.S. and global Mo-99 market
and would work toward a certification
to Congress, regarding the sufficiency of
supply as soon as the statutory
conditions are satisfied.
Based on an expert third party market
analysis, as well as the assessment of
subject matter experts in both agencies,
the Secretary of Energy and the
Secretary of Health and Human Services
have jointly certified that there is a
sufficient global supply of Mo-99
produced without the use of HEU
available to meet the needs of patients
in the United States. Furthermore, while
there is the potential for future shortages
of other medical isotopes, including
iodine-131 and xenon-133, the export of
HEU would not mitigate these risks.
Therefore, the Secretaries also have
jointly certified that it is not necessary
to export United States-origin HEU for
the purposes of medical isotope
production in order to meet United
States patient needs.
E:\FR\FM\27DEN1.SGM
27DEN1
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
This joint certification reflects DOE’s
progress in working with international
partners to convert medical isotope
production facilities to the use of low
enriched uranium (LEU) and in
supporting the establishment of
domestic supplies of Mo-99 produced
without use of HEU. Three of the four
major global producers now produce
Mo-99 using LEU. The other major
producer still relies partially on HEU
but is on track to convert to LEU-based
processes in 2022. The Department of
Health and Human Services has also
played a critical role in achieving this
milestone, including approval of LEU
Mo-99 technologies and through the
2018 approval of a New Drug
Application for the first domestic
production of Mo-99 in nearly 30 years.
The global market is now capable of
producing enough Mo-99 using LEU to
meet U.S. demand, but ongoing
engagement between producers,
radiopharmaceutical companies, and
other private sector stakeholders will be
needed to ensure that U.S. patient needs
continue to be met. Mo-99 producers
must continue to coordinate regarding
the security of global supply and must
maintain the ability to ramp up
production where needed to
compensate for shortfalls from other
producers and maintain accessibility of
Mo-99 through the supply chain. DOE
will reinforce this message through its
ongoing engagements with the Mo-99
community.
khammond on DSKJM1Z7X2PROD with NOTICES
Signing Authority
This document of the Department of
Energy was signed on December 8, 2021,
by Corey Hinderstein, Deputy
Administrator for Defense Nuclear
Nonproliferation, pursuant to delegated
authority from the Secretary of Energy.
That document with the original
signature and date is maintained by
DOE. For administrative purposes only,
and in compliance with requirements of
the Office of the Federal Register, the
undersigned DOE Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of the Department of
Energy. This administrative process in
no way alters the legal effect of this
document upon publication in the
Federal Register.
Signed in Washington, DC, on December
21, 2021.
Treena V. Garrett,
Federal Register Liaison Officer, U.S.
Department of Energy.
[FR Doc. 2021–28017 Filed 12–23–21; 8:45 am]
BILLING CODE 6450–01–P
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
page of any filing should include docket
number P–1888–038.
For further information, contact Alicia
Burtner at (202) 502–8038 or
Alicia.Burtner@ferc.gov.
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[Project No. 1888–038]
York Haven Power Company, LLC;
Notice of Availability of Environmental
Assessment
In accordance with the National
Environmental Policy Act of 1969 and
the Federal Energy Regulatory
Commission’s (Commission)
regulations, 18 CFR part 380, the Office
of Energy Projects has reviewed the
application for a temporary variance
from flow requirements for the York
Haven Hydroelectric Project, located on
the Susquehanna River in Dauphin,
Lancaster, and York counties,
Pennsylvania, and has prepared an
Environmental Assessment (EA) for the
project. The project does not occupy
Federal lands.
The EA contains the staff’s analysis of
the potential environmental effects of
the temporary variance and concludes
that licensing the variance would not
constitute a major federal action that
would significantly affect the quality of
the human environment.
The EA may be viewed on the
Commission’s website at https://
www.ferc.gov using the ‘‘elibrary’’ link.
Enter the docket number (P–1888) in the
docket number field to access the
document. At this time, the Commission
has suspended access to the
Commission’s Public Reference Room,
due to the proclamation declaring a
National Emergency concerning the
Novel Coronavirus Disease (COVID–19),
issued by the President on March 13,
2020. For assistance, contact FERC
Online Support at
FERCOnlineSupport@ferc.gov or tollfree at 1–866–208–3372, or for TTY,
(202) 502–8659.
All comments must be filed within 30
days from the date of this notice. The
Commission strongly encourages
electronic filing. Please file comments
using the Commission’s eFiling system
at https://www.ferc.gov/docs-filing/
efiling.asp. Commenters can submit
brief comments up to 6,000 characters,
without prior registration, using the
eComment system at https://
www.ferc.gov/docs-filing/
ecomment.asp. You must include your
name and contact information at the end
of your comments. For assistance,
please contact FERC Online Support. In
lieu of electronic filing, please send a
paper copy to: Secretary, Federal Energy
Regulatory Commission, 888 First Street
NE, Washington, DC 20426. The first
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
73271
Dated: December 20, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021–28025 Filed 12–23–21; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[Docket No. CP22–29–000]
Columbia Gas Transmission, LLC;
Notice of Request Under Blanket
Authorization and Establishing
Intervention and Protest Deadline
Take notice that on December 8, 2021,
Columbia Gas Transmission, LLC
(Columbia), 700 Louisiana Street, Suite
1300, Houston, Texas 77002–2700, filed
in the above referenced docket a prior
notice pursuant to sections 157.205 and
157.216(b) of the Commission’s
regulations under the Natural Gas Act
(NGA) and its blanket certificate issued
in Docket No. CP83–76–000 requesting
authorization to abandon 11 injection/
withdrawal wells, 12 associated storage
pipelines, and appurtenances at its
Holmes and Wayne Storage Field in
Holmes and Wayne Counties, Ohio.
Columbia states that these wells provide
little value with each contributing a de
minimis amount to the total
deliverability of the storage field and
plugging and abandoning each well will
reduce integrity risk. Columbia also
seeks to abandon 0.99 miles of storage
lines in place and 0.14 miles of storage
lines by removal; Columbia will no
longer have a use for these lines once
the wells are abandoned. Columbia
estimates the cost of the project to be
approximately $7 million. Columbia
avers that the proposed abandonment
will have no impact on its existing
customers or affect its existing storage
operations. Columbia states that there
will be no change its the existing
boundary, total inventory, reservoir
pressure, reservoir and buffer
boundaries, or certificated capacity of
the Holmes and Wayne Storage Field as
a result of the proposed abandonment,
all as more fully set forth in the request
which is on file with the Commission
and open to public inspection.
In addition to publishing the full text
of this document in the Federal
Register, the Commission provides all
interested persons an opportunity to
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 86, Number 245 (Monday, December 27, 2021)]
[Notices]
[Pages 73270-73271]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28017]
-----------------------------------------------------------------------
DEPARTMENT OF ENERGY
National Nuclear Security Administration
Exports of U.S.-Origin Highly Enriched Uranium (HEU) for Medical
Isotope Production: Certification of Sufficient Supplies of Non-HEU-
based Molybdenum-99 (Mo-99) To Meet Needs of Patients in the United
States
AGENCY: National Nuclear Security Administration (NNSA), Department of
Energy (DOE).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: DOE and Department of Health and Human Services (HHS), in
accordance with the American Medical Isotopes Production Act of 2012
(AMIPA), have issued a joint Secretarial certification that there is a
sufficient global supply of Mo-99 produced without the use of HEU
available to meet the needs of patients in the United States and that
it is not necessary to export United States-origin HEU for the purposes
of medical isotope production in order to meet United States patient
needs. This certification is effective as of January 2, 2022.
FOR FURTHER INFORMATION CONTACT: Requests for additional information
may be sent to Max Postman in the Office of Conversion
[email protected] or 202-586-9114.
SUPPLEMENTARY INFORMATION:
Authority and Background:
The American Medical Isotopes Production Act of 2012 (AMIPA)
(subtitle F, Title XXXI of the National Defense Authorization Act for
Fiscal Year 2013 (Pub. L. 112-139)), enacted on January 2, 2013,
amended section 134 of the Atomic Energy Act of 1954 (42 U.S.C. 2160d)
by striking subsection c. and inserting language that prohibits the
Nuclear Regulatory Commission (NRC) from issuing a license for the
export of HEU from the United States for the purposes of medical
isotope production, effective seven years after enactment of AMIPA,
subject to a certification regarding the sufficiency of Mo-99 supply in
the United States.
AMIPA requires the Secretary of Energy to either jointly certify,
with the Secretary of Health and Human Services, that there is a
sufficient supply of Mo-99 produced without the use of HEU available to
meet U.S. patient needs, and that it is not necessary to export U.S.-
origin HEU for the purposes of medical isotope production in order to
meet U.S. patient needs, or to unilaterally certify that there is
insufficient supply of Mo-99 produced without the use of HEU available
to satisfy the domestic market and that the export of U.S.-origin HEU
for the purposes of medical isotope production is the most effective
temporary means to increase the supply of Mo-99 to the domestic U.S.
market, thereby delaying the enactment of the export license ban for up
to six years.
DOE published a Federal Register notice (85 FR 3362) on January 21,
2020 certifying that, at the time, there was an insufficient global
supply of Mo-99 produced without the use of HEU and that the export of
U.S.-origin HEU for the purposes of medical isotope production was the
most effective temporary means to increase the supply of Mo-99 to the
domestic U.S. market. This certification was effective for no more than
two years from the effective date of January 2, 2020. The Federal
Register notice stated that DOE would conduct periodic reviews of the
domestic U.S. and global Mo-99 market and would work toward a
certification to Congress, regarding the sufficiency of supply as soon
as the statutory conditions are satisfied.
Based on an expert third party market analysis, as well as the
assessment of subject matter experts in both agencies, the Secretary of
Energy and the Secretary of Health and Human Services have jointly
certified that there is a sufficient global supply of Mo-99 produced
without the use of HEU available to meet the needs of patients in the
United States. Furthermore, while there is the potential for future
shortages of other medical isotopes, including iodine-131 and xenon-
133, the export of HEU would not mitigate these risks. Therefore, the
Secretaries also have jointly certified that it is not necessary to
export United States-origin HEU for the purposes of medical isotope
production in order to meet United States patient needs.
[[Page 73271]]
This joint certification reflects DOE's progress in working with
international partners to convert medical isotope production facilities
to the use of low enriched uranium (LEU) and in supporting the
establishment of domestic supplies of Mo-99 produced without use of
HEU. Three of the four major global producers now produce Mo-99 using
LEU. The other major producer still relies partially on HEU but is on
track to convert to LEU-based processes in 2022. The Department of
Health and Human Services has also played a critical role in achieving
this milestone, including approval of LEU Mo-99 technologies and
through the 2018 approval of a New Drug Application for the first
domestic production of Mo-99 in nearly 30 years.
The global market is now capable of producing enough Mo-99 using
LEU to meet U.S. demand, but ongoing engagement between producers,
radiopharmaceutical companies, and other private sector stakeholders
will be needed to ensure that U.S. patient needs continue to be met.
Mo-99 producers must continue to coordinate regarding the security of
global supply and must maintain the ability to ramp up production where
needed to compensate for shortfalls from other producers and maintain
accessibility of Mo-99 through the supply chain. DOE will reinforce
this message through its ongoing engagements with the Mo-99 community.
Signing Authority
This document of the Department of Energy was signed on December 8,
2021, by Corey Hinderstein, Deputy Administrator for Defense Nuclear
Nonproliferation, pursuant to delegated authority from the Secretary of
Energy. That document with the original signature and date is
maintained by DOE. For administrative purposes only, and in compliance
with requirements of the Office of the Federal Register, the
undersigned DOE Federal Register Liaison Officer has been authorized to
sign and submit the document in electronic format for publication, as
an official document of the Department of Energy. This administrative
process in no way alters the legal effect of this document upon
publication in the Federal Register.
Signed in Washington, DC, on December 21, 2021.
Treena V. Garrett,
Federal Register Liaison Officer, U.S. Department of Energy.
[FR Doc. 2021-28017 Filed 12-23-21; 8:45 am]
BILLING CODE 6450-01-P
